UK markets open in 7 hours 1 minute
NIKKEI 225
38,079.70 +117.90 (+0.31%) HANG SENG
16,385.87 +134.03 (+0.82%) CRUDE OIL
82.63 -0.10 (-0.12%) GOLD FUTURES
2,396.10 -1.90 (-0.08%) DOW
37,775.38 +22.07 (+0.06%) Bitcoin GBP
51,062.11 +1,796.47 (+3.65%)
ResMed Inc. (RMD)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 173.83 |
| Open | 177.40 |
| Bid | 177.35 x 800 |
| Ask | 177.47 x 1000 |
| Day's range | 176.33 - 179.80 |
| 52-week range | 132.24 - 243.52 |
| Volume | |
| Avg. volume | 1,030,470 |
| Market cap | 26.124B |
| Beta (5Y monthly) | 0.67 |
| PE ratio (TTM) | 29.45 |
| EPS (TTM) | 6.03 |
| Earnings date | 25 Apr 2024 |
| Forward dividend & yield | 1.92 (1.10%) |
| Ex-dividend date | 07 Feb 2024 |
| 1y target est | 202.68 |
Investor's Business DailyHow The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher
ResMed stock jumped Thursday after an analyst suggested the growing popularity of weight-loss drugs could drive use of its medical devices.
ZacksResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Investor's Business DailyEli Lilly Pops After Weight-Loss Drug Succeeds In Highly Anticipated Sleep Apnea Test
Eli Lilly stock popped Wednesday after the company's weight-loss drug significantly reduced nighttime sleep apnea events.
© 2024 Yahoo. All rights reserved.